Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
prophylactic hepatitis C virus vaccine
- Development stage
- Preclinical
- Lead developer
- GeneCure Biotechnologies
- Modality
- Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Injection
01
Overview
Developed by GeneCure Biotechnologies, this is a preclinical-stage lentiviral vector-based vaccine designed for the prevention of Hepatitis C virus (HCV) infection. It utilizes the company's proprietary SimVec platform, which employs a non-replicating, non-integrating lentiviral vector to deliver HCV-specific antigens. The vaccine is intended to induce a robust and protective immune response, including both cellular and humoral immunity, to prevent initial HCV infection. The SimVec platform is designed to overcome the limitations of traditional viral vectors by providing high-level antigen expression without the risk of genomic integration.
- Other names
- Prophylactic HCV vaccine
Beyond the preview
Go deeper on prophylactic hepatitis C virus vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on prophylactic hepatitis C virus vaccine.